HKD 4.46
(-3.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 19.06 Million CNY | 0.0% |
2022 | - CNY | -100.0% |
2021 | 22.68 Million CNY | 0.0% |
2020 | - CNY | -100.0% |
2019 | 3.83 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 248.63 Million CNY | 0.0% |
2024 Q1 | 248.63 Million CNY | 0.0% |
2023 Q4 | - CNY | 0.0% |
2023 FY | 19.06 Million CNY | 0.0% |
2023 Q3 | - HKD | -100.0% |
2023 Q2 | 9.53 Million CNY | 0.0% |
2023 Q1 | 9.53 Million CNY | 0.0% |
2022 Q3 | - CNY | 0.0% |
2022 Q2 | - CNY | 0.0% |
2022 FY | - CNY | -100.0% |
2022 Q4 | - CNY | 0.0% |
2022 Q1 | - CNY | -100.0% |
2021 Q1 | - CNY | 0.0% |
2021 Q3 | 11.34 Million CNY | 0.0% |
2021 FY | 22.68 Million CNY | 0.0% |
2021 Q4 | 11.34 Million CNY | 0.0% |
2021 Q2 | - CNY | 0.0% |
2020 Q1 | 100 Thousand CNY | 0.0% |
2020 FY | - CNY | -100.0% |
2019 FY | 3.83 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 95.148% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 97.989% |